Telemedicine catches ROP, NEI study finds

Article

A National Eye Institute (NEI) study found that telemedicine can effectively screen for retinopathy of prematurity (ROP) and could potentially ease the strain on hospitals with limited access to ophthalmologists.

A National Eye Institute (NEI) studyfound that telemedicine can effectively screen for retinopathy of prematurity (ROP) and could potentially ease the strain on hospitals with limited access to ophthalmologists.

Second Sight, Kellog Eye Center finding early success with artificial retina

The study evaluated telemedicine for ROP screening during the care of 1,257 premature babies. Every nine days or so, each infant was screened by an ophthalmologist, who assessed whether referral treatment was warranted. Either immediately before or after that exam, a staff member took photos of babies’ eyes, which were sent to a secure server at the University of Oklahoma, Oklahoma City for evaluation by staff who were trained to recognize signs of severe ROP. The staff then made recommendations on whether the infant should be referred to an eyecare professional for further treatment.

The non-physician image readers in Oklahoma City correctly identified 90 percent of the infants that needed a referral based on examination by an ophthalmologist, and they correctly identified 87 percent of the infants who did not need a referral. The examining ophthalmologists documented 244 infants with ROP who needed a referral on exam, 162 of whom were treated. Of these, non-physician image readers identified ROP that warranted a referral in all but three infants (98 percent).

According to NEI, some signs of ROP appear in about half of infants born at or before 30 weeks, but only five to eight percent of those cases become severe enough to require treatment. 

Recent Videos
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
© 2025 MJH Life Sciences

All rights reserved.